GlassScriptPhysician profile
Amy J Pence
NPI 1477824217
$2,331.82
in general payments reported to CMS, 2019-2025
16 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $584 · 2022: $676 · 2023: $463 · 2024: $439 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $714.40 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $363.40 | 2022-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $222.91 | 2021-2024 | Farxiga, Brilinta |
| Pfizer INC. | $213.94 | 2023-2025 | |
| Abbott Laboratories | $169.38 | 2021-2025 | Cardiomems |
| Boston Scientific Corporation | $140.90 | 2021 | |
| Alexion Pharmaceuticals, INC. | $124.13 | 2023 | |
| Medtronic, INC. | $112.41 | 2022-2024 | Corevalve Evolut R |
| Impulse Dynamics (USA) INC. | $94.06 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.58 | 2021-2022 | |
| Scpharmaceuticals INC. | $39.40 | 2024-2025 | |
| Chiesi USA, INC. | $26.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.62 | 2022 | |
| Edwards Lifesciences Corporation | $14.95 | 2022 | |
| Shockwave Medical, INC | $14.87 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Pence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.